Antiplatelet and anticoagulation for patients with prosthetic heart valves (Q24201287)

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Anticoagulation therapy with combined low dose aspirin and warfarin following mechanical heart valve replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude medical prosthesis: a clinical and transesophageal echocardiographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Pharmacologic Control of Thromboembolic Complications of Cardiac-Valve Replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Standard versus low-level anticoagulation combined to low-dose dipyridamole after mitral valve replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Should unpublished data be included in meta-analyses? Current convictions and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Antithrombotic therapy in patients with heart valve prostheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

The promise of novel direct oral anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Quantitative Synthesis in Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Platelet-active drugs : the relationships among dose, effectiveness, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: A metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

7 January 2021

Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: Danger of aspirin compared with dipyridamole

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

7 January 2021

Combined warfarin and antiplatelet therapy after St. Jude Medical valve replacement for mitral valve disease

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

7 January 2021

Effects of dipyridamole in combination with anticoagulant therapy on survival and thromboembolic events in patients with prosthetic heart valves. A meta-analysis of the randomized trials

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

7 January 2021

Influence of low-intensity anticoagulation and low-dose antiplatelet agent on coagulation-fibrinolysis system after mechanical prosthetic valve replacement

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

7 January 2021

Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

7 January 2021

Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003464.PUB2

7 January 2021